Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsTorrentpharmaceuticals

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Torrent Pharma good bet: Vishal Malkan

      According to Vishal Malkan of malkansview.com, Torrent Pharmaceuticals is a good bet in the pharmaceutical space.

    • Prefer MindTree, Cadila, LIC Housing: Dipan Mehta

      Dipan Mehta, Member of BSE & NSE is of the view that one may prefer MindTree, Zensar Technologies, Cadila Healthcare and LIC Housing Finance.

    • See downside in L&T; HCL Tech top pick: Ambit Capital

      According to Saurabh Mukherjea, CEO-Institutional Equities at Ambit Capital, one may see downside in Larsen and Toubro and UltraTech Cement.

    • Top buzzing midcap stocks to trade on September 10

      Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - UPL, Rallis India, Glenmark Pharmaceutical, Torrent Pharmaceutical, Suven Life Sciences, Jindal Steel and Power Limited (JSPL), Uttam Galva, Bhushan Steel, Shree Pushkar Chemicals & Fertilisers & Pennar Engineered Building Systems.

    • Alembic, Marico qualify as today‘s A-list stocks

      CNBC-TV18's research team brings you the cherry-picked companies from among thousands of listed stocks, which stand out on their own fundamentals. Two worthy of an A-list stature are Alembic Pharma and Marico.

    • Look at L&T, Torrent Pharma: Kunal Bothra

      Kunal Bothra of LKP Securities is of the view that one may look at Larsen and Toubro and Torrent Pharma.

    • Divis Lab, Torrent Pharma good buys: Daljeet Singh Kohli

      Daljeet Singh Kohli of India Nivesh Securities is of the view that Divis Laboratories and Torrent Pharmaceuticals are still good buys.

    • Buy Torrent Pharma on dips, advises Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one can buy Torrent Pharma on dips.

    • Like Divis Laboratories, Torrent Pharma: Anmol Ganjoo

      Anmol Ganjoo of JM Financial likes Divis Laboratories and Torrent Pharma from the pharma space.

    • Positive on pharma, like Aurobindo Pharma: Dipan Mehta

      Dipan Mehta, Member at BSE & NSE is extremely positive on the pharma industry but feels that Sun Pharma will underperform.

    • Why India Nivesh is bullish on Torrent Pharma, BoB

      Daljeet Singh Kohli, head of research at India Nivesh Securites is bullish on Torrent Pharma, Pitti Laminations, Bank of Baroda and Federal Bank.

    • Prefer midcap pharma space: Hemindra Hazari

      Hemindra Hazari, independent market expert is of the view that Midcap pharma is going to be a better bet because large cap pharma.

    • Overweight on pharma, private sector banks: Dipan Mehta

      Dipan Mehta - member at BSE & NSE maintains overweight position on pharma as well as private sector banks.

    • Buy Pennar Ind, Torrent Pharma: Daljeet Singh Kohli

      Daljeet Singh Kohli of India Nivesh Securities has a buy rating on midcap stocks like Pennar Industries and Torrent Pharma.

    • See better Q2 for Infy; buy HDFC Bank: India Nivesh Sec

      Daljeet Singh Kohli expects better performance of Infosys to continue in Q2 as well and thinks it is a good time to accumulate on the stock.

    • Phani Sekhar positive on largecap pharma space

      Phani Sekhar, Fund Manager--PMS at Karvy Stock Broking has a positive view on largecap pharma space.

    • Portfolio churner: 10 stocks to buy/sell as Greece haunts

      So, as Indian market gets back to its feet again, here are 10 stocks that you can buy or sell as suggested by Ambit.

    • See 10-15% upside in midcap pharma space: Vineet Bhatnagar

      Vineet Bhatnagar - MD at Phillip Capital expects 10-15 percent upside in midcap pharma stocks including Glenmark Pharma, Divis Laboratories, Torrent Pharma and Cadila Healthcare.

    • Buy Glenmark, Colgate Palmolive: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Colgate Palmolive and Glenmark Pharma.

    • Here are top 10 stocks to focus on April 6

      Here are top 10 stocks to focus on April 6 - Idea Cellular, Aban Offshore, IGL, Reliance Infra, Tata Power, Sun Pharma, Coal India, TVS Motor, Hero Moto and Tata Motors.

    • Hold Cadila, Torrent Pharma, Infosys, TCS: Rajesh Kothari

      Rajesh Kothari, MD, AlfAccurate Advisors advises holding Cadila Healthcare, Torrent Pharma, Infosys, HCL Tech and TCS.

    • Fancy a large cap 'gladiator' stock in your kitty?

      The stock hit an all-time high of Rs 1223 towards January-end 2015 and, thereafter, entered a sideways corrective phase to work off the short-term overstretched conditions developed after the strong rally from October 2014 low of Rs 811 to January life-time highs.

    • Prefer Dr Reddy's, Lupin, Cipla, Ipca Labs: Anmol Ganjoo

      Anmol Ganjoo of JM Financial Institutional Securities is of the view that one may prefer Dr Reddy's Laboratories, Lupin, Cipla, Ipca Labs and Torrent Pharma.

    • Here are top 10 stocks to keep an eye on December 24

      Here are top 10 stocks to keep an eye on December 24 - GMR Infra, Torrent Pharma, JP Associates, Ultratech Cement, Nirlon, Godrej Industries, Sobha Developers, Fulford India, Marico and Gujarat Gas.

    • Bullish on pharma; buy Lupin, Dr Reddys, Ipca: JM Financial

      For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347